spironolactone has been researched along with Weight Gain in 4 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gamliel-Lazarovich, A | 1 |
| Raz-Pasteur, A | 1 |
| Coleman, R | 1 |
| Keidar, S | 1 |
| Armani, A | 1 |
| Cinti, F | 1 |
| Marzolla, V | 1 |
| Morgan, J | 1 |
| Cranston, GA | 1 |
| Antelmi, A | 1 |
| Carpinelli, G | 1 |
| Canese, R | 1 |
| Pagotto, U | 1 |
| Quarta, C | 1 |
| Malorni, W | 1 |
| Matarrese, P | 1 |
| Marconi, M | 1 |
| Fabbri, A | 1 |
| Rosano, G | 1 |
| Cinti, S | 1 |
| Young, MJ | 1 |
| Caprio, M | 1 |
| Gross, E | 1 |
| Rothstein, M | 1 |
| Dombek, S | 1 |
| Juknis, HI | 1 |
| Ramanathan, M | 1 |
1 trial available for spironolactone and Weight Gain
| Article | Year |
|---|---|
Effect of spironolactone on blood pressure and the renin-angiotensin-aldosterone system in oligo-anuric hemodialysis patients.
Topics: Adult; Aldosterone; Antihypertensive Agents; Anuria; Blood Pressure; Body Weight; Cross-Over Studies | 2005 |
3 other studies available for spironolactone and Weight Gain
| Article | Year |
|---|---|
The effects of aldosterone on diet-induced fatty liver formation in male C57BL/6 mice: comparison of adrenalectomy and mineralocorticoid receptor blocker.
Topics: Adrenalectomy; Aldosterone; Animals; Blood Glucose; Blood Pressure; Cells, Cultured; Cholesterol; Di | 2013 |
Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adipose Tissue, White; Aldosterone; Androstenes; An | 2014 |
Idiopathic oedema: a lesson in differential diagnosis.
Topics: Adult; Diagnosis, Differential; Edema; Female; Humans; Spironolactone; Urination Disorders; Weight G | 1994 |